These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9123245)

  • 1. An investigation of "tolerance" induction following islet allotransplantation in the mouse.
    Asakura T; Gray DW; Ozasa T; Wood KJ; Morris PJ
    Transplant Proc; 1997; 29(1-2):1152. PubMed ID: 9123245
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomodulation with ionizing radiation does not prolong fish-to-mouse islet xenograft survival.
    Yang H; Kearns H; Wright JR
    Transplant Proc; 1995 Dec; 27(6):3312-3. PubMed ID: 8539966
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of unresponsiveness to islet xenografts by a short-course treatment by anti-CD4 nondepleting monoclonal antibody.
    Lu X; Schulz M; Zihlmann HR; Borel JF
    Transplant Proc; 1998 Mar; 30(2):552-3. PubMed ID: 9532173
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-CD45RB treatment prolongs islet allograft survival in mice.
    Auersvald LA; Rothstein DM; Oliveira SC; Khuong CQ; Basadonna GP
    Transplant Proc; 1997; 29(1-2):771. PubMed ID: 9123520
    [No Abstract]   [Full Text] [Related]  

  • 5. Paracrine enhancement of porcine to murine islet xenograft survival by simultaneous fetal pancreas and fetal liver isografts.
    Squiers EC; Hodell M; Tice DG; Adams GA; Dafoe DC
    Biochem Soc Trans; 1997 May; 25(2):288S. PubMed ID: 9191332
    [No Abstract]   [Full Text] [Related]  

  • 6. Toward a new device for islet cell immunoisolation in pancreatic transplantation.
    van der Vliet JA; Bonthuis F; Marquet RL; Feyen J
    Transplant Proc; 1992 Jun; 24(3):955. PubMed ID: 1604682
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of nonimmunological factors in islet graft failure.
    Juang JH; Kuo CH; Hsu BR
    Transplant Proc; 2000 Aug; 32(5):1076-8. PubMed ID: 10936365
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of cryopreservation on islet recovery and in vivo function.
    Cattral MS; Lakey JR; Warnock GL; Kneteman NM; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3336. PubMed ID: 8539978
    [No Abstract]   [Full Text] [Related]  

  • 9. Islet allografts: rejection and tolerance induction.
    Turvey SE; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):645. PubMed ID: 10083277
    [No Abstract]   [Full Text] [Related]  

  • 10. Islet graft primary nonfunction and its prevention.
    Arita S; Smith CV; Nagai T; Sakamoto Y; Maruyama M; Mullen Y
    Transplant Proc; 2000 Nov; 32(7):1667. PubMed ID: 11119883
    [No Abstract]   [Full Text] [Related]  

  • 11. Donor-recipient cross has marked impact on islet survival and primary nonfunction.
    Weide LG
    Transplant Proc; 1997 Jun; 29(4):2196. PubMed ID: 9193587
    [No Abstract]   [Full Text] [Related]  

  • 12. Early changes in syngeneic islet grafts: effect of recipient's metabolic control on graft outcome.
    Davalli AM; Scaglia L; Zangen DH; Hollister J; Bonner-Weir S; Weir GC
    Transplant Proc; 1995 Dec; 27(6):3238-9. PubMed ID: 8539932
    [No Abstract]   [Full Text] [Related]  

  • 13. Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts.
    Ohzato H; Porter J; Monaco AP; Maki T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):953-4. PubMed ID: 8442277
    [No Abstract]   [Full Text] [Related]  

  • 14. FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats.
    Tze WJ; Tai J; Cheung SS; Ricordi C; Murase N; Starzl TE
    Transplant Proc; 1992 Jun; 24(3):1034-6. PubMed ID: 1376509
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of type II diabetes in Zucker rats by xenogeneic pancreas islet transplant.
    Thomas FT; Pittman K; Thomas JM
    Transplant Proc; 1992 Apr; 24(2):647-8. PubMed ID: 1566464
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolongation of islet allograft survival following immunologic conditioning by antigen-feeding in the pig.
    Hrstka J; Hesse UJ; Hrstka V; Danis J; Schmitz-Rode M; Tunggal B; Hördegen P; Peters S
    Transplant Proc; 1992 Apr; 24(2):663-4. PubMed ID: 1566472
    [No Abstract]   [Full Text] [Related]  

  • 17. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
    Duvivier-Kali VF; Omer A; Parent RJ; O'Neil JJ; Weir GC
    Diabetes; 2001 Aug; 50(8):1698-705. PubMed ID: 11473027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in allograft survival of islets of Langerhans by pretreatment with deoxyguanosine.
    al-Abdullah IH; Kumar MS; al-Adnani MS; Abouna GM
    Diabetes Res; 1991 Aug; 17(4):181-7. PubMed ID: 1823639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mouse islet isografts from early transplantation damage by nicotinamide treatment of recipients.
    Kenmochi T; Mullen Y; Miyamoto M; Stein E
    Transplant Proc; 1994 Apr; 26(2):693. PubMed ID: 8171611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.